Showing results (291-300 of 304) with videos related to

Sort By:
Pageof 31
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 10, 2006
Revisiting late loss and neointimal volumetric measurements in a drug-eluting stent trial: analysis from the SPIRIT FIRST trialKeiichi Tsuchida, Héctor M García-García, Andrew T L Ong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2005
Phase I clinical and pharmacokinetic study of kahalalide F in patients with advanced androgen refractory prostate cancerJeany M Rademaker-Lakhai, Simon Horenblas, Willem Meinhardt, et al.
European Journal of Epidemiology|September 20, 2005
Phenotypic subtypes in attention deficit hyperactivity disorder in an isolated populationEsther A Croes, Rachid El Galta, Jeanine J Houwing-Duistermaat, et al.
Acta Oncologica (Stockholm, Sweden)|March 7, 2020
Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancerAnouk K M Claessens, Frans L G Erdkamp, Marta Lopez-Yurda, et al.
The British Journal of Dermatology|March 26, 2003
Beneficial effects of fumarate therapy in psoriasis vulgaris patients coincide with downregulation of type 1 cytokinesN H R Litjens, P H Nibbering, A J Barrois, et al.
Clinical Oral Investigations|November 22, 2016
Growth and prevalence of feeding difficulties in children with Robin sequence: a retrospective cohort studyEmma C Paes, Iris A C de Vries, Wouter M Penris, et al.
Breast (Edinburgh, Scotland)|February 20, 2025
Side-effects in women treated with adjuvant endocrine therapy for breast cancerL M Rademaker, R Gal, A M May, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Phase I pharmacokinetic and pharmacodynamic study of the oral protein kinase C beta-inhibitor enzastaurin in combination with gemcitabine and cisplatin in patients with advanced cancerJeany M Rademaker-Lakhai, Laurens V Beerepoot, Niven Mehra, et al.
Pageof 31